IVF Hartmann Net Income Over Time
| VBSN Stock | CHF 138.00 1.00 0.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IVF Hartmann Performance and IVF Hartmann Correlation. IVF |
Cross Equities Net Income Analysis
Compare IVF Hartmann Holding and related stocks such as Coltene Holding AG, Newron Pharmaceuticals, and DocMorris AG Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLTN | 13.3 M | 6 M | 9.5 M | 13.2 M | 15.6 M | 13.3 M | 17.3 M | 19.1 M | 14.9 M | 20 M | 8.2 M | 31.7 M | 26 M | 11.9 M | 20.5 M | 18.4 M | 14.5 M |
| NWRN | (14.9 M) | (6.4 M) | (2.4 M) | (7.1 M) | (10.1 M) | (22.8 M) | (15.2 M) | (5.3 M) | (15 M) | (20.2 M) | (21 M) | (14.9 M) | (17.5 M) | (16.2 M) | 15.8 M | 18.2 M | 19.1 M |
| DOCM | 3.9 M | 8.7 M | 6.2 M | (15.5 M) | 7.2 M | 3.4 M | (12.8 M) | (36.2 M) | (39 M) | (52.4 M) | (135.7 M) | (225.7 M) | (171.1 M) | 82.3 M | (97.3 M) | (87.5 M) | (83.2 M) |
| ASCN | (67.8 M) | 23.1 M | 20.9 M | 36.9 M | 38.5 M | 24.3 M | (145.7 M) | 25.9 M | 21.4 M | 500 K | 6.5 M | 13.5 M | 11 M | 17.4 M | 3.7 M | 3.3 M | 3.2 M |
| SANN | (28.3 M) | (27.8 M) | (31.4 M) | (5.8 M) | (7.5 M) | 5.9 M | (35.4 M) | (51.5 M) | (54.2 M) | (19 M) | (67.7 M) | (55.5 M) | (71.1 M) | 54.8 M | (42 M) | (37.8 M) | (39.7 M) |
| BSLN | (59 M) | (57.6 M) | (53 M) | (33 M) | (41.5 M) | (61.6 M) | (51.3 M) | (19.4 M) | (31.4 M) | (22.4 M) | (14.7 M) | (6.8 M) | 12.1 M | 10.5 M | 77.6 M | 40.2 M | 42.2 M |
| MOLN | 7.1 M | 7.1 M | 7.1 M | 7.1 M | (2.3 M) | (148.8 K) | (18.6 M) | (25.4 M) | (37 M) | (36.3 M) | (62.8 M) | (63.8 M) | 117.9 M | (62 M) | (54 M) | (48.6 M) | (46.2 M) |
| SHLTN | 1.4 M | 4 M | (7.3 M) | 2.2 M | 829 K | (16.6 M) | (11.1 M) | 2.4 M | 10.1 M | 5.7 M | 278 K | (14.1 M) | (76 K) | (7.1 M) | (28.1 M) | (25.3 M) | (24 M) |
| ADXN | (20.5 M) | (31.1 M) | (27 M) | (14.5 M) | (1.8 M) | (4.2 M) | (3.1 M) | (3.3 M) | (1.6 M) | (14.8 M) | (12.9 M) | (15.4 M) | (20.8 M) | (10.6 M) | 7.1 M | 8.1 M | 8.5 M |
IVF Hartmann Holding and related stocks such as Coltene Holding AG, Newron Pharmaceuticals, and DocMorris AG Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in IVF Hartmann Holding financial statement analysis. It represents the amount of money remaining after all of IVF Hartmann Holding operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| IVF Hartmann Holding | VBSN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Victor von Bruns-Strasse |
| Exchange | SIX Swiss Exchange |
CHF 138.0
Additional Tools for IVF Stock Analysis
When running IVF Hartmann's price analysis, check to measure IVF Hartmann's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IVF Hartmann is operating at the current time. Most of IVF Hartmann's value examination focuses on studying past and present price action to predict the probability of IVF Hartmann's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IVF Hartmann's price. Additionally, you may evaluate how the addition of IVF Hartmann to your portfolios can decrease your overall portfolio volatility.